Genetic Technologies Limited
GNTLFOTCHealthcare● Active
$1.00
+$0.00(+0.00%)
Market Cap$1.3B
P/E Ratio—
52W High$1
52W Low$1
Genetic Technologies Limited (GNTLF) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · GNTLF · as of 2026-06-08
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2024-06 | 2023-06 | 2022-06 | 2021-06 | 2020-06 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $9.67M | $10.35M | $9.22M | $1.33M | $0.84M |
| Cost of Revenue | $3.76M | $4.34M | $0.32M | $0.36M | $0.10M |
| Gross Profit | $3.90M | $6.01M | $6.47M | ($0.24M) | $0.74M |
| Gross Margin %(computed) | 40.37% | 58.10% | 70.23% | -18.02% | 87.89% |
| Operating Expenses | |||||
| R&D Expenses | $0.75M | $1.28M | $0.71M | $1.17M | $0.87M |
| G&A Expenses | $10.22M | $9.01M | $2.18M | $4.16M | $2.31M |
| Total Operating Expenses | $12.45M | $12.08M | $11.02M | $6.96M | $6.98M |
| Operating Income | ($12.21M) | ($6.07M) | ($4.81M) | ($5.80M) | ($5.94M) |
| Operating Margin %(computed) | -126.23% | -58.62% | -52.19% | -434.49% | -708.77% |
| Interest Income | $0.12M | $0.22M | $0.04M | $0.06M | $0.02M |
| Interest Expense | $0.05M | $0.03M | $0.02M | $0.01M | $0.01M |
| Income Before Tax | ($12.02M) | ($11.91M) | ($7.16M) | ($7.08M) | ($6.29M) |
| Income Tax Expense | $0.00M | ($0.16M) | ($0.03M) | $0.00M | ($0.75M) |
| Net Income | ($12.02M) | ($11.75M) | ($7.13M) | ($7.08M) | ($6.29M) |
| Net Margin %(computed) | -124.24% | -113.56% | -77.36% | -530.26% | -751.29% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-0.09 | $-0.12 | $-0.08 | $-0.08 | $-0.15 |
| Wtd Avg Shares | 138.37M | 101.38M | 92.20M | 85.44M | 41.55M |
| EBITDA | ($11.43M) | ($11.20M) | ($7.20M) | ($7.16M) | ($5.87M) |
| EBITDA Margin %(computed) | -118.17% | -108.26% | -78.11% | -536.12% | -700.99% |
Data source: Financial Modeling Prep · Last updated: 2026-06-08 · AUD · M
Explore more Genetic Technologies Limited data
About Genetic Technologies Limited (GNTLF) Income Statement
Genetic Technologies Limited (GNTLF) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2024, GNTLF reported revenue of $0.01B, gross profit of $0.00B (gross margin 40.37%), and net income of ($0.01B) — a net profit margin of -124.24%.
Frequently asked questions
GNTLF · 4 questionsGenetic Technologies Limited (GNTLF) reported revenue of $0.01B for 2024, down 6.5% year-over-year.
GNTLF revenueGNTLF salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08